Table 2-6819.
Weeks* | Treatment groups | Lymphocytes population (%) (mean ± SEM)
|
HIV-1 p24 pg/ml (mean ± SEM) | ||
---|---|---|---|---|---|
CD3+† | CD4+† | CD8+† | |||
Week 1 | Control | 44.99 ± 1.06 | 15.32 ± 1.08 | 22.25 ± 0.79 | 2.07 ± 0.59 |
Ethanol | 44.21 ± 1.13 | 16.27 ± 0.67 | 18.02 ± 0.32 | 5.84 ± 1.08 | |
Week 2 | Control | 62.86 ± 0.35 | 32.31 ± 0.37 | 26.97 ± 0.25 | 24.6 ± 14.43 |
Ethanol | 65.01 ± 0.68 | 30.53 ± 0.46 | 31.32 ± 0.26 | 132.13 ± 58.47‡ |
Days after MDM injection.
No significant difference in percentage of CD3+/CD8+/CD4+ cells between the groups.
P < 0.032, compared with control.